Articles

Original Research

10.4244/EIJ-D-25-00826 Dec 1, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trial
Rossello X, Sánchez P, Owen R, Raposeiras-Roubin S, Poletti F, Barrabés J, Anguita M, Dominguez-Rodriguez A, Lombardi M, Pocock S, Díez-Villanueva P, Vives-Borras M, Rollán M, D’Orazio S, Escalera N, Isabel-Santos A, Chiampan A, de Diego O, López-Benito M, Moreno E, Rincón-Díaz L, París H, Latini R, Fuster V, Ibáñez B
open access

Original Research

10.4244/EIJ-D-25-00566 Dec 1, 2025
Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: prespecified analysis from the MASTER DAPT trial
Landi A, Mahfoud F, Frigoli E, Chalkou K, Heg D, Abhaichand R, Abhyankar A, Barbato E, Beygui F, Danse P, Garachemani A, del Blanco B, Huber K, Koning R, Kukreja N, Piot C, Quang N, Tirouvanziam A, Valla M, Smits P, Valgimigli M, obotMDi

Flashlight

10.4244/EIJ-D-25-00791 Dec 1, 2025
Reducer migration and coronary sinus thrombosis
Portolan L, Kotronias R, Langrish J, De Maria G

Original Research

10.4244/EIJ-D-25-00423 Nov 14, 2025
TRICURE: first-in-human study of the Topaz transcatheter tricuspid heart valve system
Teiger E, Nejjari M, Rosseel L, Kefer J, Verheye S, Lancellotti P, Oliver L, Obadia J, Asch F, Blanke P, Dreyfus J
open access

Flashlight

10.4244/EIJ-D-25-00195 Nov 14, 2025
Five-year follow-up of transcatheter tricuspid valve replacement with the EVOQUE valve
Millar K, Husain A, Moss R, Boone R, Webb J

Letter to the editor

10.4244/EIJ-D-25-00842 Nov 14, 2025
Letter: Transcatheter aortic valve implantation and covert brain injury: does silence equal reassurance?
Pyrpyris N, Beneki E, Dimitriadis K, Tsioufis K
free

Reply to the letter to the editor

10.4244/EIJ-D-25-00890 Nov 14, 2025
Reply: Transcatheter aortic valve implantation and covert brain injury: does silence equal reassurance?
Jimenez Diaz V, Salvadores P, Lamas P, obotAi
free

Original Research

10.4244/EIJ-D-24-01050 Nov 14, 2025
Assessment of coronary cannulation after TAVI with the Evolut FX valve: the CANNULATE TAVR EXPANDED study
Ohno Y, Kamioka N, Miyamoto J, Omura R, Horinouchi H, Hashimoto K, Noda S, Murakami T, Ikari Y, Okada K, Frazzetto M, Raheja H, Lodi H, Rushing G, Ukaigwe A, Filby S, Yoon S, Feroze R, Palma Dallan L, Attizzani G, obotCTEi

Editorial

10.4244/EIJ-E-25-00046 Nov 14, 2025
HALT – an evolving understanding of the mechanisms of formation and clinical relevance
Leipsic J, Khoo J
free

Editorial

10.4244/EIJ-E-25-00041 Nov 14, 2025
Transcatheter aortic valve alignment: substantial progress, remaining gaps
Amat-Santos I, Pensotti F
free

Viewpoint

10.4244/EIJ-D-25-00692 Nov 14, 2025
Discontinuation of the ACURATE transcatheter heart valve platform: loss or reckoning?
Kim W, Möllmann H
free

State-of-the-Art

10.4244/EIJ-D-24-01069 Nov 14, 2025
Transcatheter treatment of bicuspid aortic valve stenosis
Tchétché D, Willemen Y, Cesario V, Backer O
free

Original Research

10.4244/EIJ-D-25-00523 Nov 14, 2025
Incidence, predictors, and clinical impact of hypoattenuating leaflet thickening following SAPIEN 3 Ultra RESILIA implantation
Ishizu K, Shirai S, Hayashi M, Morofuji T, Isotani A, Ohno N, Kakumoto S, Ando K, Yamamoto M, Ochiai T, Tsunaki T, Hioki H, Shimura T, Yashima F, Asami M, Yamanaka F, Ohno Y, Nakazawa G, Hachinohe D, Fuku Y, Otsuka T, Hayashida K, of the OCEAN-TAVI investigators o
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved